Task force 2: Investigator participation in clinical research

Robert M. Califf, Steven E. Nissen, Anthony N. Demaria, Erik Magnus Ohman, Bertram Pitt, James T. Willerson, David W. Bilheimer, Jay N. Cohn, David W. Feigal, Lindsay Hampson, Beverly H. Lorell, Carl J. Pepine, Richard L. Popp

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)1729-1736
Number of pages8
JournalJournal of the American College of Cardiology
Volume44
Issue number8
DOIs
StatePublished - Oct 19 2004

Bibliographical note

Funding Information:
Although the majority of cardiovascular clinical research is funded by the industry, a significant minority is funded from public sources, most notably the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). However, the NHLBI and the NIH as a whole are encouraging public-private partnerships for clinical research (www.nihroadmap.nih.gov) , in which resources from both sectors are combined to cover the enormous cost of technology development and evaluation. The principles of appropriate investigator participation are applicable across the range of funding sources, including industry, public sources, and public-private partnerships.

Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.

Cite this